المؤلفون: Timmermann , Beate, Alapetite, Claire, Dieckmann, Karin, Kortmann, Rolf-Dieter, Lassen-Ramshad, Yasmin, Maduro, John, Ramos Albiac, Monica

المساهمون: Institut Català de la Salut, Timmermann B Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Center (WTZ), Germany, German Cancer Consortium (DKTK), Germany. Alapetite C Department of Radiation Oncology and Proton Therapy Center, Institut Curie, Paris-Orsay, France. Dieckmann K Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria. Kortmann RD Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Center (WTZ), Germany, German Cancer Consortium (DKTK), Germany. University of Leipzig Medical Center, Leipzig, Germany. Lassen-Ramshad Y Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark. Maduro JH Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, the Netherlands. Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Ramos Albiac M Servei d’Oncologia Radioteràpica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Cervell - Càncer - Radioteràpia, Sistema nerviós central - Càncer - Radioteràpia, Infants, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Complex and Mixed::Rhabdoid Tumor, Other subheadings::Other subheadings::Other subheadings::/radiotherapy, Germ Cell and Embryonal::Teratoma, DISEASES::Neoplasms::Neoplasms by Site::Nervous System Neoplasms::Central Nervous System Neoplasms::Brain Neoplasms, NAMED GROUPS::Persons::Age Groups::Child, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias complejas y mixtas::tumor rabdoide, Otros calificadores::Otros calificadores::Otros calificadores::/radioterapia, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de células germinales y embrionarias::teratoma, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias del sistema nervioso::neoplasias del sistema nervioso central::neoplasias cerebrales, DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::niño

وصف الملف: application/pdf

Relation: Radiotherapy and Oncology;196; https://doi.org/10.1016/j.radonc.2024.110227; Timmermann B, Alapetite C, Dieckmann K, Kortmann RD, Lassen-Ramshad Y, Maduro JH, et al. ESTRO-SIOPE guideline: Clinical management of radiotherapy in atypical teratoid/rhabdoid tumors (AT/RTs). Radiother Oncol. 2024 Mar 14;196:110227.; https://hdl.handle.net/11351/11395

الاتاحة: https://hdl.handle.net/11351/11395
https://doi.org/10.1016/j.radonc.2024.110227

المؤلفون: Wick, Antje, Desjardins, Annick, Suárez Rodríguez, Cristina, Forsyth, Peter, Gueorguieva, Ivelina, Burkholder, Tiana, Rodon Ahnert, Jordi

المساهمون: Institut Català de la Salut, Wick A Clinical Cooperation Unit Neuro-oncology, German Cancer Research Center, Heidelberg University Medical Center, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. Desjardins A The Preston Robert Tisch Brain Tumor Center at Duke, Duke University, Durham, NC, USA. Suarez C Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Forsyth P H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Gueorguieva I Eli Lilly and Company, Erl Wood, UK 6 Eli Lilly and Company, Indianapolis, IN, USA. Burkholder T Eli Lilly and Company, Indianapolis, IN, USA. Rodon J Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, U. T. M. D. Anderson Cancer Center, Houston, TX, USA, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Gliomes, Cervell - Càncer - Quimioteràpia, Cervell - Càncer - Radioteràpia, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Germ Cell and Embryonal::Neuroectodermal Tumors::Neoplasms, Neuroepithelial::Glioma, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Combined Modality Therapy::Chemoradiotherapy, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de células germinales y embrionarias::tumores neuroectodérmicos::neoplasias neuroepiteliales::glioma, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::tratamiento combinado::quimiorradioterapia

وصف الملف: application/pdf

Relation: Investigational New Drugs;38; https://doi.org/10.1007/s10637-020-00910-9; Wick A, Desjardins A, Suarez C, Forsyth P, Gueorguieva I, Burkholder T, et al. Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma. Invest New Drugs. 2020 Oct;38:1570–1579.; https://hdl.handle.net/11351/6463; 000518298200001

الاتاحة: https://hdl.handle.net/11351/6463
https://doi.org/10.1007/s10637-020-00910-9

المؤلفون: Susan C. Guba, Jordi Rodon, Tiana L. Burkholder, Ann Cleverly, David Capper, Antje Wick, Peter A. Forsyth, Cristina Suarez, Michael Lahn, Annick Desjardins, Shawn T. Estrem, Shuaicheng Wang, Ivelina Gueorguieva

المساهمون: Institut Català de la Salut, [Wick A] Clinical Cooperation Unit Neuro-oncology, German Cancer Research Center, Heidelberg University Medical Center, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. [Desjardins A] The Preston Robert Tisch Brain Tumor Center at Duke, Duke University, Durham, NC, USA. [Suarez C] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Forsyth P] H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. [Gueorguieva I] Eli Lilly and Company, Erl Wood, UK 6 Eli Lilly and Company, Indianapolis, IN, USA. [Burkholder T] Eli Lilly and Company, Indianapolis, IN, USA. [Rodon J] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, U. T. M. D. Anderson Cancer Center, Houston, TX, USA, Vall d'Hebron Barcelona Hospital Campus

المصدر: Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Scientia
Investigational New Drugs
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Receptor, Transforming Growth Factor-beta Type I, Phase II Studies, Cervell - Càncer - Quimioteràpia, Cervell - Càncer - Radioteràpia, neoplasias::neoplasias por tipo histológico::neoplasias de células germinales y embrionarias::tumores neuroectodérmicos::neoplasias neuroepiteliales::glioma [ENFERMEDADES], 0302 clinical medicine, T-Lymphocyte Subsets, Gliomes, Therapeutics::Combined Modality Therapy::Chemoradiotherapy [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Antineoplastic Combined Chemotherapy Protocols, Pharmacology (medical), Brain Neoplasms, Chemoradiotherapy, Glioma, Middle Aged, Tolerability, Neoplasms::Neoplasms by Histologic Type::Neoplasms, Germ Cell and Embryonal::Neuroectodermal Tumors::Neoplasms, Neuroepithelial::Glioma [DISEASES], 030220 oncology & carcinogenesis, Quinolines, Female, medicine.drug, medicine.medical_specialty, Galunisertib, T cells, Antineoplastic Agents, Newly diagnosed, 03 medical and health sciences, Pharmacokinetics, Internal medicine, medicine, Biomarkers, Tumor, Temozolomide, Humans, Protein Kinase Inhibitors, Radiochemotherapy, Aged, Pharmacology, business.industry, medicine.disease, terapéutica::tratamiento combinado::quimiorradioterapia [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Regimen, 030104 developmental biology, Pharmacodynamics, Pyrazoles, business, Glioblastoma, Biomarkers

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf14df256fb85a93fde079c6fea17c04
http://hdl.handle.net/2072/441889